
The Aflac Duck and Chemotherapy: How One Company Is Creating a Companion to Help Children with Cancer
Chemotherapy is difficult, and in children even more so. Sproutel has teamed up with Aflac to create a companion robot to help children undergo chemotherapy easier.
Seeing children with cancer has never been something that I found professionally I could do. It's probably why I prefer a geriatric population. My limited experiences standout with the tears and sadness in the parents, and for the children as they underwent chemotherapy and supportive care. I always enjoyed the programs that hospitals and staff would engage in to help make the stay manageable and encourage playtime for the kids. For that reason, when I heard about a new supportive toy being developed to help kids undergoing chemotherapy, I had to write about it, because it is novel and I can see how children may like it.
Several years ago, I had the opportunity to see the creators talk about their journey in creating Jerry, and how they spent time with patients to make a fulfilling product. It wasn't easy, and I think that is really one of the issues when trying to get this type of device right for a difficult market.
Their most recent product unveiled is the
The duck is adorable. Watch the
Now, companion robots aren't new. There are a bunch on the market, and I stand by the cutest one I have seen: the
Aside from robots, other products have sought to have patients care for a digital companion ,as well. One,
In any event, the Aflac Duck will hopefully be available soon, and I would highly encourage pharmacists to let parents know that this is something that their children could get once released.
References
- Sproutel. www.sproutel.com/. Accessed January 12, 2018.
- This robotic duck is helping kids with cancer find comfort through the scariest parts of treatment. People. http://people.com/human-interest/robotic-duck-for-kids-with-cancer-aflac/. Published January 2018. Accessed January 12, 2018.
- PARO Therapeutic Robot. www.parorobots.com/. Accessed January 12, 2018.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.